RS
Rayma Singla
About Rayma Singla
Data last updated:
Rayma Singla has 4 years in corporate governance. Holds Director role. Currently with 3 companies, including Opi Dermaceuticals Private Limited and Rrg Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Rrg Biotech Private Limited at ₹159 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 06 Apr 2022 | 2021 | ₹159 Cr (FY 2025) | Active | |
| Director | 29 Jun 2024 | 2021 | – | Active | |
| Director | 26 Dec 2023 | 2021 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rayma Singla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rayma Singla
Rayma Singla has 4 years in corporate governance. Holds Director role. Currently with 3 companies, including Opi Dermaceuticals Private Limited and Rrg Biotech Private Limited. Engaged in General Business, Technology. Contributes to corporate operations. The largest current company by reported revenue is Rrg Biotech Private Limited at ₹159 Cr (FY 2025).
Rayma Singla is associated with 3 companies as Director, including Rrg Biotech Private Limited (₹159 Cr), Opi Dermaceuticals Private Limited, Opi Pharma Private Limited.
Rayma Singla has expertise in General Business, Technology.
Rayma Singla has 4 years in corporate governance.
By reported revenue, the largest current company of Rayma Singla is Rrg Biotech Private Limited, with revenue of ₹159 Cr (FY 2025).
Rayma Singla currently holds positions at 3 companies: Rrg Biotech Private Limited (₹159 Cr), Opi Dermaceuticals Private Limited, Opi Pharma Private Limited.